TIP regimen: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}}Taxol-Ifosfamide-Platinol Regimen; TIP Regimen ==Overview== {{PAGENAME}} refers to a regimen consisting of paclitaxel, i...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[paclitaxel]], [[ifosfamide]], [[mesna]] and [[cisplatin]] used for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent [[head and neck cancer|squamous cell head and neck cancer]].<ref name=" | {{PAGENAME}} refers to a regimen consisting of [[paclitaxel]], [[ifosfamide]], [[mesna]] and [[cisplatin]] used for the treatment of advanced-stage [[testicular cancer]]<ref name="pmid16170162">{{cite journal| author=Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J et al.| title=Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 27 | pages= 6549-55 | pmid=16170162 | doi=10.1200/JCO.2005.19.638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16170162 }} </ref>; also used for the treatment of unresectable and recurrent [[head and neck cancer|squamous cell head and neck cancer]].<ref name="pmid10697043">{{cite journal| author=Shin DM| title=Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. | journal=Semin Oncol | year= 2000 | volume= 27 | issue= 1 Suppl 1 | pages= 36-40 | pmid=10697043 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10697043 }} </ref> | ||
==Regimen== | ==Regimen== | ||
| Line 13: | Line 12: | ||
{{chemo|I|Ifosfamide}} | {{chemo|I|Ifosfamide}} | ||
{{chemo|P|Platinol (cisplatin)}} | {{chemo|P|Platinol (cisplatin)}} | ||
==Indications== | ==Indications== | ||
*[[ | *[[testicular cancer|Advanced-stage testicular cancer]]<ref name="pmid16170162">{{cite journal| author=Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J et al.| title=Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 27 | pages= 6549-55 | pmid=16170162 | doi=10.1200/JCO.2005.19.638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16170162 }} </ref>, [[head and neck cancer|Squamous cell head and neck cancer]]<ref name="pmid10697043">{{cite journal| author=Shin DM| title=Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. | journal=Semin Oncol | year= 2000 | volume= 27 | issue= 1 Suppl 1 | pages= 36-40 | pmid=10697043 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10697043 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63490&ns=NCI_Thesaurus}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] | ||
Latest revision as of 15:08, 30 March 2015
|
WikiDoc Resources for TIP regimen |
|
Articles |
|---|
|
Most recent articles on TIP regimen Most cited articles on TIP regimen |
|
Media |
|
Powerpoint slides on TIP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on TIP regimen at Clinical Trials.gov Clinical Trials on TIP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on TIP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on TIP regimen Discussion groups on TIP regimen Patient Handouts on TIP regimen Directions to Hospitals Treating TIP regimen Risk calculators and risk factors for TIP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for TIP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Taxol-Ifosfamide-Platinol Regimen; TIP Regimen
Overview
TIP regimen refers to a regimen consisting of paclitaxel, ifosfamide, mesna and cisplatin used for the treatment of advanced-stage testicular cancer[1]; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.[2]
Regimen
TTaxol (paclitaxel)
IIfosfamide
PPlatinol (cisplatin)
Indications
References
- ↑ 1.0 1.1 Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J; et al. (2005). "Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors". J Clin Oncol. 23 (27): 6549–55. doi:10.1200/JCO.2005.19.638. PMID 16170162.
- ↑ 2.0 2.1 Shin DM (2000). "Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck". Semin Oncol. 27 (1 Suppl 1): 36–40. PMID 10697043.
- ↑ "NCI Thesaurus".